Published in
Ferrata Storti Foundation, Haematologica, 9(101), p. 1065-1073
DOI: 10.3324/haematol.2016.143677
Links
- ORCID
- ORCID
- ORCID
- Ferrata Storti Foundation | PDF
- [europepmc.org] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
Tools
Safety and efficacy of ruxolitinib in an open-label, multicenter, single-arm phase 3b expanded-access study in patients with myelofibrosis: a snapshot of 1144 patients in the JUMP trial
Journal article published in 2016 by
H. K. Al-Ali 
,
M. Griesshammer,
P. le Coutre,
C. F. Waller ,
A. M. Liberati,
P. Schafhausen,
R. Tavares,
P. Giraldo,
L. Foltz,
P. Raanani,
V. Gupta ,
B. Tannir,
J. P. Ronco,
J. Ghosh,
B. Martino
and other authors.
,
M. Griesshammer,
P. le Coutre,
C. F. Waller ,
A. M. Liberati,
P. Schafhausen,
R. Tavares,
P. Giraldo,
L. Foltz,
P. Raanani,
V. Gupta ,
B. Tannir,
J. P. Ronco,
J. Ghosh,
B. Martino
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving forbidden
Postprint:
archiving forbidden
Data provided by 